Lonza CEO Wolfgang Wienand to present at Jefferies Global Healthcare Conference
Published on 11/04/2026 at 14:00 | dgap, AD HOC NEWS| Lonza Group AG / Key word(s): Conference 04.11.2026 / 14:00 CET/CEST Basel, Switzerland, 4 November 2026 – Lonza is pleased to announce that it will participate in the Jefferies Global Healthcare Conference in London on 17 and 18 November 2026. As part of the conference, Lonza CEO Wolfgang Wienand will host a presentation and subsequent Q&A on 18 November from 15:30 – 15:55 GMT (16:30 – 16:55 CET). The session will be webcast live, and a replay will be available on the Lonza Investor Relations website, remaining accessible for 90 days. The live audio webcast can be accessed via this link. About Lonza Lonza is the world’s leading contract development and manufacturing organization (CDMO) dedicated to serving the healthcare industry. Working across three continents, Lonza’s global team of approximately 17,000 colleagues1 works alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. This enables customers to bring life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing. Our company generated sales of CHF 3.4 billion with a CORE EBITDA of CHF 1.2 billion in Half-Year 2026. Find out more at www.lonza.com. 1 For Lonza’s continuing CDMO business, excluding Capsules & Health Ingredients. Lonza Contact Details Daniel Buchta Head of Investor Relations Lonza Group Ltd Tel +41 61 316 2985 daniel.buchta@lonza.com Additional Information and Disclaimer Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual. All trademarks belong to Lonza, and are registered in the USA, EU and/or CH, or used in common law, or belong to their respective third-party owners and are used for informational purposes only. Privacy Policy link To immediately delete all the data End of Media Release View original content: EQS News |
| Language: | English |
| Company: | Lonza Group AG |
| Münchensteinerstrasse 38 | |
| 4052 Basel | |
| Switzerland | |
| Phone: | +4161 316 81 11 |
| Internet: | www.lonza.com |
| ISIN: | CH0013841017 |
| Valor: | 1384101 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2427858 |
| End of News | EQS News Service |
| |
en | CH0013841017 | LONZA GROUP AG | boerse | 70456853 |
